Insider filing
Traded Dec 1, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 6, 2025 · Filed Nov 10, 2025
A Bruker director sold $243K of Bruker shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$243,087
Shares × reported transaction price
3 days after results of Nov 3, 2025, 67 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $39.31 on Nov 6, 2025, 34% above its 52-week low and 38% below its high, after a 28% rise over the previous 30 trading days
52-week range $29.35 (Sep 3, 2025) to $62.95 (Jan 13, 2025), 30% of the way up, from 250 adjusted closes. 30 trading days earlier: $30.78 on Sep 25, 2025. Describes the past only, not a forecast
RSI 58, 2% under its 200-day average, 13% above its 50-day average, 38% below the 52-week high, 20-day volatility 46% a year, against the S&P 500: +14 points over 1 month, +24 points over 3 months, −22 points over 6 months
From the adjusted closes up to Nov 6, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.2% | −3.4% | +5.6% |
| 30 days | +11.1% | +0.9% | +10.2% |
| 90 days | +0.9% | +1.6% | −0.7% |
| 180 days | +3.7% | +8.2% | −4.5% |
| 365 days | +49.6% | +11.3% | +38.3% |
Past results only. Not a forecast.
Insider filing
Traded Dec 1, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Insider selling
Traded Dec 1, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
A Bruker director sold $243K of Bruker shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Dec 1, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.